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Summary 
Dendritic cells are potent antigen-presenting cells for several  primary immune responses and therefore 
provide an opportunity for evaluating the amounts of cell-associated antigens that are required 
for inducing T cell-mediated immunity. Because dendritic calls express very high levels of major 
histocompatibility complex (MHC) class II products, it has been assumed that high levels of 
ligands bound to MHC products ("signal one") are needed to stimulate quiescent T cells. Here 
we describe quantitative aspects underlying the stimulation of human blood T cells by a bacterial 
superantigen, staphylococcal enterotoxin A (SEA). The advantages of superantigens for quantitative 
studies of signal one are that these ligands:  (a) engage MHC class II and the T  cell receptor 
but do not require processing; (b) are efficiently presented to large numbers of quiescent T cells; 
and (c) can be pulsed onto dendritic cells before their application to T cells. Thus one can relate 
amounts  of  dendritic  cell-associated  SEA  to  subsequent  lymphocyte  stimulation.  Using 
radioiodinated SEA, we noted that dendritic cells can bind 30-200 times more superantigen than 
B cells and monocytes. Nevertheless, this high SEA binding does not underlie the strong potency 
of dendritic cells to present antigen to T  cells. Dendritic cells can sensitize quiescent T  cells, 
isolated using monoclonals to appropriate CD45R epitopes, after a pulse of SEA that occupies 
a maximum of 0.1% of surface MHC class II molecules. This corresponds to an average of 2,000 
molecules per dendritic cell. At these low doses of bound SEA, monoclonal antibodies to CD3, 
CD4,  and CD28 almost completely block T  cell proliferation. In addition to suggesting new 
roles for MHC class II on dendritic ceils, especially the capture and retention of ligands at low 
external concentrations, the data reveal that primary T calls can generate a response to exceptionally 
low levels of signal one as long as these are ddivered on dendritic ceils. 
D 
uring the initiation of an immune response, the antigen 
receptor-CD3 complex on T lymphocytes engages ei- 
ther peptide fragments or superantigens bound to MHC mol- 
ecules on APCs,  an event that is commonly referred to as 
"signal one:' To date there is little quantitative information 
on signal one using quiescent T cells. There are reports using 
cell lines as APCs and/or T  cells (1, 2) where it has been 
found that only a few hundred MHC-peptide complexes are 
needed to stimulate IL-2 release from T-T hybridomas, for 
example. The affinity of these T cell lines may not be repre- 
sentative of bulk T cells, however, and the signal one require- 
ments may be lower than quiescent T cells. The use of APCs 
and T cell lines may also obscure the contribution of acces- 
sory molecules that are thought to lead to the full comple- 
ment of events that are needed during T  cell growth and 
differentiation. Superantigens provide a means to pursue quan- 
titative aspects of antigen presentation to human T cells. These 
molecules, many of them staphylococcal enterotoxins (SEs)  1, 
resemble processed peptide antigens in the sense that they 
engage both  the MHC  class  II  molecules and  the TCK 
(reviewed in reference 3). The experimental advantage of su- 
perantigens is that they do not require cellular processing (4, 
5), so that one can better quantitate with trace-radiolabeled 
materials the amount of ligand associated  with the APCs. 
Superantigen-pulsed APCs, particularly dendritic cells, stimu- 
late responses in large numbers of quiescent T  cells  (6). 
In this paper we use superantigens and dendritic cells in 
combination to gain information on the levels of signal one 
that are needed for primary T  cell stimulation.  Several re- 
t Abbreviation used in this paper: SE, staphylococcal enterotoxin. 
633  J.  Exp. Med.  ￿9  The Rockefeller University Press ￿9 0022-1007/93/08/0633/10 $2.00 
Volume 178  August 1993  633-642 sponses are initiated by antigen-bearing  dendritic cells, in- 
cluding the induction of helper T  cells for protein antigens 
(7, 8) and transplant rejection in situ (9, 10). Dendritic cells 
express very high levels of MHC class II, so that it has been 
tacitly assumed that the efficacy of these APCs relates to the 
higher  amounts  of MHC-peptide  complexes  that  can be 
presented. Alternatively, function may be attributed to the 
presence on dendritic cells of several accessory molecules for 
T  cell signaling  (11).  These hypotheses have been difficult 
to pursue directly, since it has not been possible to measure 
the levels of conventional antigenic peptides that are presented 
on MHC products by dendritic cells. Here we use radioiodi- 
nated SEA and human blood dendritic cells to gain such quan- 
titative information.  While blood dendritic cells,  not sur- 
prisingly, bind much higher levels of SEA than other APCs, 
we find that very small numbers of superantigen-MHC class 
II complexes are sufficient to trigger resting primary T  cells. 
At these low doses, triggering entails a major role of both 
CD4 and  CD28  accessory molectdes. 
Materiah  and Methods 
Culture Medium.  R.PMI  1640 (Gibco Laboratories,  Grand Is- 
bud, NY), supplemented with 5% human serum, 50 gg/ml gen- 
tamycin, and 10 mM Hepes was used throughout these studies ex- 
cept where indicated.  Human  sera were obtained from normal 
donors and were screened to ensure that they supported SEA-induced 
T cell proliferation at femtomolar concentrations. Sera used were 
similar  to FCS in inducing responses  to SEA (data not shown). 
Commercial sources  of pooled human sera, however,  have been 
problematic in supporting SEA-induced proliferation, presumably 
because of the presence of antistaphylococcal antibodies,  and were 
not used here. 
Prelmration of Lymphoid Cells.  Burly coats were obtained from 
the New York Blood Center and separated  into T  cell-enriched 
(ElL +)  and  T  cell-depleted (ElL-)  fractions by rosetting  with 
neuraminidase-treated SRBC. 
T  Cells.  ER + cells were depleted of non-T cell contaminants 
first by panning on petri dishes coated with human gamma globulin 
to remove FcR+ cells (12), and then coating MHC class II-posi- 
tire cells with  anti-DlL/DQ  mAb  9.3C9  (IgG2a,  subclone of 
HB180; American Type Culture Collection, lLockville, MD) fol- 
lowed by panning on petri dishes coated with goat anti-mouse 
IgG (55459; Cappel Laboratories, Organon Teknika, Durham, NC 
[13, 14]). In some experiments T lymphocytes were prepared by 
passage of nonadherent ElL  + cells over nylon wool columns be- 
fore panning with anti-MHC class II antibodies.  The resulting T 
cell preparations failed to proliferate to optimal doses of superan- 
tigens,  indicating negligible contamination with APCs. 
CD4 + T  Cells.  These were enriched by negative selection  of 
bulk T cells. The latter were incubated with o~CD8 (OKT8, IgG2a, 
ATCC CRL 8014) and c~2Dllb (OKM1, IgG2b, ATCC CRL 8026) 
and panned on petri dishes  coated with goat anti-mouse IgG. 
Naive and memory CD4 + subsets  were negatively selected in a 
similar fashion by panning CD4 + T cells coated with c,CD45RO 
(UCHL-1, IgG2a; gift of Dr. P.C.L. Beverley, Imperial Cancer Re- 
search Technology, London, UK) or ~CD45RA (4G10, IgG2a), 
respectively. CeUs depleted by panning constituted g2-3% of the 
resulting subpopulation as monitored by cytofluorography. The en- 
richment of CD4 + naive and memory T  cell subsets  was moni- 
tored by their relative responses  to a crude extract of Candida al- 
bicans diluted 1:20 final in the presence  of APCs. 
APC Popu/at/0ns.  To obtain monocytes, the ElL- or T-depleted 
fraction was adhered to plastic for 60-90 min and subsequently 
dislodged by pipetting. The nonadherent non-T cells were subse- 
quently used for purification of  B cells and dendritic cells, lLesidual 
monocytes were first depleted from these populations by panning 
on gamma globulin-coated plates (12) and then layered onto 13-14 
g% metrizamide (15). After sedimentation at 650 g for 10 min, 
B cells and a few NK cells localized to the high-density pellet while 
dendritic cells were enriched in the low-density interface. The pu- 
rity of dendritic cells ranged from 50 to 75% with contaminants 
being primarily small B and NK cells. 
Lyraphoblastoid Cell Lines.  The Cox (MHC class II +) and Ket 
(BLS1, MHC class II-) cell lines were gifts of Dr. P. Cameron and 
Dr. J. S. Lee (16), respectively.  They were maintained in 1LPMI 
supplemented with 10% FCS. We confirmed that the Ket cell lines 
lacked surface expression of  class II molecules by staining with anti- 
MHC class II antibodies. 
Mitogens.  Highly purified SEA was purchased from Toxin Tech- 
nology (Sarasota, FL). The mitogen was aliquoted to 1 mg/ml in 
sterile  water, filtered,  and stored at  -20~  until use.  SEA was 
confirmed to be >95% pure by SDS-PAGE and Coomassie staining. 
Iodination of SEA.  SEA was iodinated using lactoperoxidase/glu- 
rose oxidase (Enzymobead Radioiodination Reagent; Bio-Rad Labs, 
Richmond, CA [17]), and specific activities ranged from 1.3 to 3.4 
x  107 cpm//~g. The eflidency of iodination was 0.14  _+ 0.04 tool 
of mI/mol of SEA (n  =  6 experiments). SEA was confirmed to 
be >95% pure by SDS-PAGE and autoradiography after iodina- 
tion. Labeled and unlabeled SEA preparations were equally effec- 
tive in stimulating T  cells (not shown). 
SEA Binding Assay.  Aliquots of 10  s to 2  x  106 of each APC 
type were incubated in 0.2 ml RPMI 1640/5% human serum and 
concentrations of 12sI-SEA ranging  from 0.015  to  150 nM  for 
1-1.5 h at 4oC or 37~  in plastic microfuge tubes over a mixture 
of phthalate oils. At the termination of the assay, the tubes were 
spun at 8,000 g  for 2 rain,  the tips containing cell pallets  were 
cut off, and this portion ("bound") plus the cell-free component 
("free") were counted in a gamma counter (18). Nonspecific binding 
was determined from parallel tubes containing a 300-fold excess 
of unlabeled toxin. 
Lymphocyte Proliferation Assays.  APCs were added directly to 
cultures of T cells in the continuous presence of SEA (nonpulsed 
APCs) or were first pulsed with SEA as described below (pulsed 
APCs). 
Nonpulsed APCs.  Graded doses of viable APCs were added to 
10  s purified T cells in 96-well flat-bottomed plates (Costar, Cam- 
bridge, MA) in the continuous presence of nSI-labeled or nonla- 
beled SEA. The APC/T ratio ranged from 1:30 to 1:1,000. The 
Cox and Ket lines were 3,-irradiated  (7,000 rad, 137Cs) to prevent 
multiplication in culture. The contribution of an allogeneic MLR 
(responders  and stimulators in the absence of superantigen) was 
minimal at the doses of APCs used and at the time points we as- 
sayed the cultures. Here, the mean [3H]TdlL uptake was <3,500 
and <2,000 cpm for Cox and Ket cells, respectively. Dendritic cells, 
monocytes, and B cells were always syngeneic to the T  cells and 
functioned similarly with or without prior irradiation. Prolifera- 
tion was determined on day 3 with the addition of 1 #Ci [3H]thy- 
midine for 12 h  to triplicate microwells  (mean cpm). 
PulsedAPCs.  For pulsing studies, APCs were incubated at 2 x 
l& cells/ml for 1-1.5  h at 4~  or 37~  with 0.005-50 nM of 
radioiodinated or nonlabeled SEA, washed extensively, and added 
back to T  cells as above. 
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used to block APC presentation of SEA to T cells. They consisted 
ofL243 (anti-DR, IgG2a, ATCC I-IB55) and 9.3F10/subclone  9.3C9 
(anti-DK/DQ, IgG2a, ATCC HB 180), Matched isotype controls 
were used at identical concentrations. 
Assays to Evaluate the Contribution of Costimulator Molecules in Su- 
perantigen Presentation.  10  s T  cells per flat-bottomed  microwell 
were incubated at 4~  for 30 min with purified mAbs of the fol- 
lowing specificities: otCD3 and etCD4 (Leu-4 and Leu-3a hybrid- 
omas, respectively, both IgG1; gifts of Dr. R. Evans, New York, 
NY); c~I-ILA  DR/DQ (9.3Pl0/subclone 9.3C9, IgG2a, ATCC HB 
180); and otCD28 (9.3, IgG2a; gift of  Dr. E.A. Clark, Seattle, WA). 
Commercial murine IgG1 (MOPC 21) and IgG2a (UPC 10; Sigma 
Chemical Co., St. Louis, MO), dialyzed free of azide, were used 
as isotype controls. Syngeneic dendritic cells were prepared as out- 
lined above and "pulsed" with SEA (0.005 nM) for 1 h at 37~ 
before mixing with T ceils at a responder/stimuhtor  ratio of 100:1. 
Table  1.  Cellular Distribution of SEA Binding Sites 
Mean no.  of sites 
Call type  per cell 
(no.  of exps.)  (range)  Mean Ka  -+  SD 
M  x  10 -9 
Cox  3.2  x  10  ~  13.4  _+ 9.3 
(n  =  5)  (0.2  x  106-6  x  10  ~) 
Dendritic  cells  1.9  x  10  s  5.6  _+ 4.5 
(n  =  7)  (0.2  x  106-3.6  x  10  ~) 
B cells  6.4  x  104  1.5  _+  0.4 
(n  =  4)  (2.3  x  104-1.2  x  10  s) 
Monocytes  9.3  x  103  1.7  _+  1.2 
(n  =  2)  (4.5  x  103-1.4  x  104  ) 
l~esuks 
SEA Binds  in Large Amounts to MHC Class II Molecules 
on Dendritic Cells and with High Affinity.  MHC class II mol- 
ecules represent the major binding sites for superantigen on 
APCs (19-24). The number of class II binding sites on den- 
dritic ceils has not been evaluated in a quantitative manner 
with iodinated superantigens. We performed binding studies 
comparing  dendritic cells to other primary populations of 
APCs such as B cells and monocytes. To quantify the amount 
of superantigen that can be bound, enriched populations of 
different APCs were exposed to iodinated SEA for 1-1.5 h 
at 4~  vs. 37~  SEA was chosen since highly purified and 
stable preparations are available. Prior studies with toxic shock 
syndrome toxin 1 (TSST-1) and SEB have shown that equi- 
librium  binding  is usually complete within  1 h  (22,  23). 
Binding of SEA to dendritic cells was compared first to the 
class II-positive and -negative B cell lines Cox and Ket/BLS1 
(the latter obtained from a patient with bare lymphocyte syn- 
drome [16]).  The binding characteristics  of iodinated SEA 
to Cox, the class II-positive B cell line,  and dendritic cells 
were similar.  Saturable binding was evident (Fig.  1 A); and 
by Scatchard analysis,  the data were consistent with a single 
receptor, most likely class II (Fig.  1 B). SEA bound to den- 
dritic  cells  and  Cox  ceils  with  high  affinity  (mean  Ka's 
ranging from 5.6 to 13.4 nM) and to similar numbers of MHC 
class  II  molecules  at  saturation  (average  of  1.9-3.2  x 
105/cdl; Table 1). It has previously been demonstrated that 
TSST-1 and SEB show saturable binding to APCs with Ka's 
in the range of 17-43 nM (19,  22) and 1/zM (20), respec- 
tively. SEA reportedly shows ,,o 10-30-fold higher affinity for 
MHC class II molecules than SEB on B cell lines (21).  For 
MHC class II-transfected L cells, Kd's for SEA range from 
82 to  143 nM (25).  DR alleles  have been shown to differ 
in their ability to bind SEA (26).  Since our dendritic cells 
were obtained from burly coat preparations, it was not pos- 
sible to correlate the Ka's measured to the DR phenotype. 
It is likely that a broad range of DR phenotypes was studied, 
as reflected by the range of Ka's obtained (Table 1). Substan- 
tial differences in on-rates for SEA at 4~  vs. 37~  have been 
described (21).  Although  large differences in Ka's at  these 
Ka values and number of SEA binding sites per cell were calculated as 
described in Fig. 1. For Cox cells and dendritic cells, 105 cells were used 
per binding assay, while higher numbers (2 x  106)  were used for mono- 
cytes and B cells. The number of SEA binding sites on dendritic cells 
may be an underestimate, since the purity of our preparations ranged 
from 50 to 75% (Fig. 1). 
two temperatures were not detected here, we did not directly 
measure the on-rate as a function of time. 
When dendritic cells or Cox cells were treated with  an 
anti-class II antibody (L243 or 9.3C9), before and during the 
SEA binding assay, at least 50% of the specific binding was 
inhibited (data not shown), similar to findings with TSST-1 
on tonsillar B cells  (19).  Control anti-CD14  antibody had 
no effect on binding of SEA to Cox cells (data not shown). 
Interestingly, the class II-negative Ket/BLS1 cell line ob- 
tained from a patient with bare lymphocyte syndrome (16) 
showed specific binding of lzsI-SEA,  but this only became 
detectable at a relatively high concentration, 15 riM, and satu- 
ration could not be achieved (Fig.  1, A  and B). An accurate 
estimate of these apparently low affinity superantigen-binding 
sites on the Ket cell line could not be determined, even when 
the numbers were increased 10-fold. Thus, besides binding 
to MHC dass II-dependent, saturable high affinity sites, SEA 
also uses an MHC class II-independent pathway to interact 
with  T  cells,  as previously suggested for SEB (27). 
Dendritic cells were then compared with other primary 
APCs from blood, i.e., B cells and monocytes. These APCs 
are known to express lower levels of MHC class II products 
than dendritic cells using cytofluorographic assays (6, 15, 28). 
When low numbers of cells were used (105/assay),  as is re- 
quired for dendritic cells,  which are a trace cell population 
in blood, saturable binding could only be achieved with den- 
dritic and B cells (Fig.  1 C). The B cells bound an average 
of 64,000 SEA molecules (range of 2.3  x  104 to 1.2  x  105), 
i.e.,  30 times less than dendritic cells. To compare dendritic 
cells with monocytes more effectively, it was necessary to in- 
crease the number of monocytes per binding assay to 2  x 
106.  Monocytes  bound  only  4,500-14,000  molecules/cell 
(Table 1), much less than the level of binding to dendritic 
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Figure  1.  Concentration-depen- 
dent binding of lZSl-labeled  SEA to 
APCs. Dendritic cells, B cells, and 
monocytes  were  enriched  from 
human buffy coat preparations as 
previously described (15). The B cell 
lines Cox and Ket/BLS1 were main- 
tained in culture as described  (see 
Materials and Methods). (.4) SEA 
binding activity of dendritic cells 
(DC), Cox cells, and Ket cells; (B) 
Scatchard  plot  analysis  of  the 
binding data in A for Cox and K~t 
cells; (C) SEA binding activity of 
dendritic cells (DC), B cells (B), and 
monocytes (Mck) obtained from the 
same donor. Scatchard plot of the 
dendritic cell data is shown in the 
inset. All binding studies were per- 
formed at 4~ 
cells,  Scatchard  plots calculated  from several experiments 
demonstrated that the affinity of binding to monocytes was 
similar to that measured on dendritic cells and the Cox cell 
line (Table 1), indicating that the receptor on these popula- 
tions (presumably MHC class II) is identical. 
Quantitation of Dendritic Cell MHC Class II-Superantigen 
Complexes Necessary  for T  Cell Stimulation.  The minimal 
number of class II molecules that must be occupied by an- 
tigen on a dendritic cell for T cell activation is not known. 
Studies with long-term APC and T  cell lines suggest that 
the amount of MHC-peptide complexes could be very small 
(200-600/APC), and the extent of MHC occupancy likewise 
~<0.1% (1, 2). It has been speculated that the large numbers 
of class II molecules on dendritic cells (6,  15, 28) account 
for their potency in several primary responses (29). To deter- 
mine how many class II molecules must be occupied by su- 
perantigen to stimulate primary T cells, we pulsed dendritic 
cells and other APCs with different doses of iodinated SEA. 
We then quantified the number of receptors bound at each 
dose, and added parallel  aliquots of APCs in graded doses 
to purified blood T cells to evaluate their functional poten- 
tial in a proliferation assay. Dendritic cells and Cox cells were 
equally stimulatory, whether pulsed with SEA or exposed 
continuously to the superantigen during cocuhure with T 
ceils (Fig. 2 A). Ket cells were only effective in stimulating 
T cells when SEA was continuously present in the cultures, 
consistent with our data that these APCs have low affinity 
SEA binding sites (Fig. 1) and probably cannot capture SEA 
weU in pulse protocols. 
SEA-pulsed B ceils and monocytes were much less effident 
stimulators of T cell proliferation than dendritic calls, even 
at higher doses of SEA and substantially higher APC/T cell 
ratios (Fig.  2 B). Dendritic ceils pulsed with 0.005 nM (5 
pM)  of  SEA  effectively  stimulated  T  cells at  ratios  of 
1:100-1,000,  whereas monocytes or B cells pulsed with up 
to 50 nM SEA induced lower responses even at APC/T cell 
ratios of 1:30 (Fig. 2 B). Dendritic cells pulsed with 1,000- 
fold less SEA (0.050 vs. 50 nM) bind similar levels of SEA 
per cell,  relative  to B cells, but are effective at <1/30 the 
number of B cells required to generate an equivalent T call 
response. For example, it was necessary to use 3.3  x  103 B 
cells (APC/T, 1:30) pulsed with 50 nM SEA to attain a similar 
degree of T cell stimulation as that obtained with 100 den- 
dritic cells (APC/T, hl,000) pulsed with only 50 pM of su- 
perantigen. 
B cells and monocytes did stimulate T  cells more effec- 
tively if SEA were continuously present in culture and at rel- 
atively high doses. Interestingly, monocytes appeared to be 
more efficient than B cells in this situation, even though the 
former bind significantly less SEA (Fig. 1 C) and have fewer 
MHC class II molecules on their surface (6,  15, 28).  Our 
studies deal with primary B cells in blood, but it is possible 
that activated B cells would resemble B cell lines and stimu- 
late superantigen responses better than resting blood B cells. 
However, is is not yet evident that superantigen or antigen 
will stimulate a sufficient number of B lymphocytes to permit 
such a function for the activated  B cell in vivo. 
The dose-response curves that describe the binding of SEA 
to dendritic cells, and the efficacy  of superantigen-pulsed APCs 
in stimulating T  cells, are strikingly different (Fig.  3). At 
stimulator-to-responder ratios of 1 dendritic cell to 100 T 
cells, half-maximal proliferation was achieved after an SEA 
pulse of only 50 pM, whereas half-maximal occupancy of 
receptors occurred at 5 nM. Therefore one needs 100-fold 
less superantigen to induce half-maximal proliferation of T 
cells than to occupy half the available high affinity receptors. 
At 50 pM SEA, the dose required for half-maximal stimula- 
tion, only 1% of receptors (presumably MHC class II) are 
bound with superantigen. At 5 pM, where strong T cell re- 
sponses are still evident, only 0.1% of receptors or •2,000 
occupied MHC molecules are required (see Table 1). 
Functional  Features  of  SEA Binding to Dendritic Cells.  Since 
dendritic ceils were active APCs when pulsed with low levels 
of superantigen, a high aff~ty binding site, most likely MHC 
dass II, seemed essential. Addition of anti-MHC dass II mAbs 
to dendritic cell-T cell cultures in the presence of SEA virtu- 
ally abrogated presenting ability to T ceUs (Fig. 4; note log 
axis, block is >95%). Similar results were obtained with the 
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Figure  2.  Presentation  of SEA 
e  cells  by different APCs. (,4) SEA-pulsed 
dendritic cells and Cox cells, but not 
MHC class If-negative Ket cells, 
....A--A--A  ef~ciently  induce  T  cell prolifera- 
P  tion. Dendritic cells, Cox cells, and 
A"  ~  Kct  ceils were  added  to  purified 
,.w..O  "-~  -  blood T cells in the continuous pres- 
[~.4~3._  O  ence  of  12sI-SEA  (nonpulsed 
APCs), or were pulsed for 1 h at 
,  ,  ,  ,  ,  ,  ....  4~  with  0.005-50  nM  of IzsI- 
SEA, washed extensively, and added 
back to T cells (pulsed APCs). The 
APC/T ratio was 1:100. Prolifera- 
B  cells  tion was determined  on day 3 with 
A....A~A_  A  the addition  of I  #Ci [3H]thymi- 
dine for 12 h to triplicate microwells 
(mean cpm). (B) Dendritic cells are 
more potent APCs than B ceils or 
monocytes in stimulating T cell re- 
sponses  to  SEA.  Dendritic  ceils 
(DC), monocytes (MS), and B cells 
derived from the same donor were 
'  ~  &  ~  ~  ~  pulsed with SEA at37~  orthe 
~  q  '  u~  APCs were added directly to T cells 
in the continuous presence of SEA 
at  various  APC/T  cell  ratios 
(1:30-1,000). 
Cox cell line, but not the MHC class II-negative Ket cell 
line (data not shown), where the induction ofT cell prolifer- 
ation was minimally affected by the addition of anti-MHC 
class II antibodies. 
We next determined if dendritic cells could retain immuno- 
genic MHC-superantigen complexes for long periods. SEA- 
pulsed dendritic cells,  in fact, retained detectable 12sI-SEA 
(not shown) and could activate T  cells if tested 48 h  after 
the pulse (Fig.  5). 
Subsets of blood T cells can be distinguished on the basis 
of isoforms of the leukocyte common antigen CD45.  The 
CD45RO +  CD45RA-  subset  contains  most  antigen- 
primed or memory T cells, whereas CD45RO-  CD45RA § 
cells do not have reactivity to these recall antigens and are 
considered to be naive (30, 31). Superantigens have been shown 
to stimulate both populations (32), but the role of dendritic 
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cells has not been evaluated. We separated blood T cells into 
CD4 + naive and memory subsets  and measured their re- 
sponses  to SEA presented by dendritic cells. Both the naive 
and memory T cells responded to dendritic cells pulsed with 
5 pM to 0.5  nM SEA (Fig.  6).  The naive population was 
more limited in its response at the lower doses of SEA, but 
was equivalent to the other populations at higher doses in 
several experiments.  To  monitor the cell populations,  we 
verified that the memory cells responded to the recall antigen 
C. albicans  while the naive cells were depleted of recall reac- 
tivity (Fig. 6, inset). These results confirm that quiescent or 
resting T  cells respond significantly to a small number of 
superantigen-MHC dass II complexes on dendritic cells. 
Contribution of Accessory or Costiraulator Molecules to the T 
Cell Response.  Dendritic ceUs are unusual among primary 
leukocytes in their comparatively high expression of acces- ￿9  100-  I 
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APC/T cell ratios. Proliferation was determined on day 3 after an over- 
night pulse with 1 #Ci of [3H]TdR. 
sory ligands for T  cell stimulation:  e.g., CD54  (ICAM-1), 
CD58  (LFA-3), and B7/BB1  (11,  15),  the respective APC 
ligands for CDlla,  CD2,  and CD28 on T  cells. It seemed 
likely that these molecules might serve as accessories to allow 
primary T cells to respond to such low doses of superantigen. 
mAbs against these accessory molecules and their ligand pairs 
can be effective blockers of T  cell responses (11, 33). In addi- 
tion, some of these molecular pairs have been shown to de- 
liver costimulatory signals together with superantigen (34--37). 
CD28  signal transduction  appears  to provide a critical co- 
stimulatory mechanism for IL-2 gene activation (35, 38, 39). 
We therefore assessed T  cell responses to dendritic cells 
pulsed with low doses of SEA in the presence of varying con- 
centrations of mAb to CD28 (9.3). The inhibition achieved 
by blocking the CD28 costimulatory pathway with an anti- 
CD28  mAb was in the 80-90%  range compared with its 
isotype-matched control (Fig. 7). This degree of inhibition 
was almost as great as that achieved by interfering with the 
antigen/MHC-CD3/TCR  complex, using mAbs to either 
CD3  or MHC  class  II,  or to the CD4  antigen. 
Discussion 
Dendritic  cells represent a widely distributed  system of 
APCs  that  is  particularly  active  for  the  induction  of T 
ceU-mediated immunity (reviewed in reference 29). Among 
the  many  stimuli  that  are  effectively delivered are  several 
microbial superantigens (6). By isolating dendritic cells from 
human blood, and by using superantigens  as the ligand to 
be presented to T  cells, several quantitative features of APC 
function have become apparent and are discussed individu- 
ally here.  Essential to the analysis is the fact that  superan- 
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Figure  6.  Dendritic cells pulsed with SEA stimulate both naive and 
memory T cells. Bulk T lymphocytes (O), CD4 + T cells (El), and naive 
(A) and  memory (~)  CD4 +  subsets were prepared as described in 
Materials and Methods. 10  s T  cells per flat-bottomed microwell were 
stimulated by syngendc dendritic cells (T/DC, 150:1) that had been pulsed 
with 0.005, 0.05, or 0.5 nM SEA for 1 h at 370C before mixing with 
T cells. All cultures were pulsed with I/~Ci pH]TdR, from 56 to 66 h. 
Proliferation was calculated from triplicate microwells (mean cpm). (Inset) 
Monitoring the enrichment of CD4 + T cell subsets. T cells from the same 
experiment outlined above were also cocuhured with syngeneic dendritic 
cells (30:1) and a crude extract ofC. albicans diluted 1:20 final. All cultures 
were pulsed with 1/~Ci [3H]TdR from 64 to 76 h (C albicans). Prolifer- 
ation was calculated from triplicate microweils (mean cpm). Data are rep- 
resentative of four experiments. 
tigens do not appear to undergo processing but instead directly 
engage MHC class II molecules on the APC and subsequently 
bind to V/3 segments of the TCR (4, 5, 21, 40). This enables 
one to pulse APCs with sutxa'antigen, and then relate amounts 
of APC-associated  superantigen  to subsequent  lymphocyte 
stimulation.  This method  has provided quantitative  infor- 
mation  on  signal  one for the  first time using  quiescent  T 
cells and APCs from humans. In addition, we have been able 
to compare superantigen binding and presentation by APCs 
quantitatively and to evaluate the contribution  of costimu- 
lator molecule pairs (signal two) when known amounts of 
ligand  are bound  to  the  APC. 
Pulse,  rather  than continuous,  exposure to superantigen 
is critical for the analysis presented here, since it permits di- 
rect measurement  of the maximal amount  of superantigen 
that is conveyed by APCs during T  cell stimulation. Mollick 
et al. (25) estimated that small amounts of bound SEA were 
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Figure 7.  Contribution  of costimuhtor molecules to dendritic cell- 
dependent superantigen-induced proliferation of T cells. 10  s bulk T lym- 
phocytes (O) and CD4 + T ceils ([]) per flat-bottomed microwell were 
incubated at  4*C  for 30  min with  purified mAbs of the  following 
specifidties: o~CD3, c~CD4, ~HLA DR/DQ, and c~CD28 (--) or isotype 
controls (-- - -). Syngeneic dendritic cells were pulsed with 0.005 nM 
SEA for 1 h at 370C before mixing with T cells at a responder/stimulator 
ratio of 100:1. The final mAb concentrations are indicated along the ab- 
scissae. Cultures  were pulsed with  1/zCi [3H]TdR from 60 to 70 h. 
Proliferation was determined from triplicate microwells (mean cpm) for 
each condition. Additional controls for [3H]TdR. incorporation (cpm  x 
10 -3 _+ SD) included T cells +  SEA-pulsed  dendritic cells in the absence 
of mAb: bulk,  17.658 _+ 4.764; CD4 +, 15.869 +_ 0.290. T calls only: 
bulk, 0.105 _+ 0.018; CD4 +, 0.104 +  0.004. SEA-pulsed dendritic cells 
only: 0.051  _+ 0.027. Data are representative of four experiments. 
sufficient for T  cell stimulation by L  cells transfected with 
MHC dass II molecules. However, the SEA was applied con- 
tinuously rather than in a pulse. During continuous exposure, 
APCs  could  accumulate  significant  amounts  of SEA  after 
binding, and reservoirs of low affinity binding sites could con- 
tribute  additional  SEA. 
Dendritic cells bind much larger amounts of superantigen 
than do other APCs like monocytes and B  cells (Fig.  1 C 
and Table 1). This might have been predicted from the higher levels of MHC class II molecules on dendritic cells (6,  15, 
28), assuming the superantigen binding sites are unoccupied. 
Because dendritic cells comprise ~0.1% of blood leukocytes 
but bind >30 times more superantigen than B cells and ~>200 
times more than monocytes, it is necessary to isolate this trace 
subset of APCs to appreciate the efficacy with which super- 
antigens can stimulate the growth of primary T  cells. Not 
only are dendritic cells much more efficient on a per cell basis 
than other primary APCs in stimulating T cells to proliferate 
to superantigen (Fig.  2 B), they also use fewer MHC class 
II molecules. We estimate that 25-30-fold fewer class II mol- 
ecules are engaged by dendritic cells compared with B ceils 
to attain a similar degree of T  cell stimulation (Pig.  2 B). 
The picomolar concentrations of superantigen that  are 
required to pulse dendritic ceils are 106-fold less  than the 
micromolar levels required for conventional soluble antigens 
(8, 41).  Since superantigens bind directly to MHC class II 
products (20-22), while most conventional antigens prob- 
ably do not bind directly and must first be processed, it is 
possible that 1/106 of a conventional antigen load is success- 
fully processed by dendritic cells to form MHC class II-pep- 
tide complexes. 
High levels of MHC class II, a uniform feature of den- 
dritic cells from many different tissues and species (29), have 
implied that high levels of signal one underlie their efficacy 
as APCs. However, this proved not to be the case for super- 
antigens at least in vitro.  An average of just 2,000 bound 
molecules of SEA per dendritic cell induced strong responses 
in quiescent T  ceils (Fig.  3 A). When one considers that 1 
dendritic cell can stimulate 10 or more T cells simultaneously 
within cell dusters (42),  and that our estimates of bound 
superantigen could be high if SEA were shed, metabolized, 
or bound in part to non-MHC products, then the number 
of MHC-associated SEA molecules that are required to stimu- 
late a primary lymphocyte is remarkably small, possibly <200 
molecules per T cell. This is true for both naive and memory 
T cell subsets, as defined by CD45RA and CD45RO markers 
(Fig.  6). These results are similar to those observed during 
presentation of MHC-peptide complexes to two T-T hybrid- 
omas (1, 2). Because prior work entailed continuous T  cell 
lines as responders, and cell lines as APCs as well, the rele- 
vance to primary T cell stimulation remained open. Our results 
show that the delivery of signal one to T  cells depends on 
the use of relatively few MHC class II-ligand pairs on den- 
dritic cells. 
That a few molecules of ligand on the dendritic cell can 
successfully stimulate a T  cell suggests a role for so-called 
accessory or costimulatory molecules. Blood dendritic cells 
express an array of various adhesion and/or costimulator mol- 
ecules (11, 15).  To evaluate their role in triggering T  cells 
with low doses of superantigen, we used blocking mAbs. 
This is feasible because human blood dendritic cells lack func- 
tioning Fc receptors, as substantiated by the failure of anti- 
CD3 to exert a mitogenic effect (11) (Fig.  7). Antibodies to 
CD3,  CD4,  and CD28 individually blocked the response 
~>80%, suggesting that each molecule makes a major contri- 
bution to T cell stimulation by low levels of MHC-superan- 
tigen complexes. The inhibition that was observed was greater 
than that documented previously in the primary MLR (11). 
Unfortunately it is not possible  to quantitate the levels of 
MHC-peptide complex that are being presented to T  cells 
in the MLK. CD28-B7-independent stimulation of T  cells 
with superantigen has been described (37). However, in these 
studies, tither high doses of SEA, added on a continuous basis, 
or APCs (B cell line) were used. Under these conditions, the 
amount  of SEA  that  binds  directly to  APCs  cannot  be 
quantified. It is possible that higher amounts of ligand may 
be less dependent on accessory molecules, as postulated for 
the CD2-CD58  (43)  and CDlla-CD54  interactions (44). 
These data provide insight on the exceptional qualities of 
the dendritic cell in eliciting primary responses.  First, den- 
dritic ceils can present low amounts of the MHC class II-SEA 
complex (signal one) and several costimulatory molecules or 
signal two (ICAM-1, LFA-3, BT/BB1 [11]) simultaneously 
to T  cells to which dendritic cells bind efficiently and for 
days (13). Second, the high number of dass II molecules (~2 
x  106) on its surface would permit the dendritic cell to bind 
several hundred peptides simultaneously, at concentrations 
that would be functionally active.  For example, 1,000 pep- 
tides, each occupying 2,000 class II molecules, could be ac- 
commodated. Thus, even if a diversity of peptides are gener- 
ated from complex antigens, assuming that they can be bound 
by class II molecules, many could be presented by the den- 
dritic cell at one time. 
If large amounts of signal one are not required for den- 
dritic cells to initiate a primary T cell response, what might 
be the function of large amounts of MHC class II on den- 
dritic cells? One function would be to allow dendritic cells 
to capture ligand (superantigens and peptides) at very low 
external concentrations. A  second is that high levels of su- 
perantigen might lead to better retention of antigen in the 
long term especially in situ. Superantigens and possibly other 
ligands dissociate from MHC molecules at a finite rate (22). 
Dendritic cells pulsed with 0.5 nM SEA are stimulatory for 
T  cells that are added as much as 2 d later (Fig.  5).  These 
possibilities  are relevant in vivo, where dendritic cells cap- 
ture antigens more efficiently than other APCs (45) and can 
migrate to the T cell areas of lymphoid tissues (46) and prime 
MHC-restricted T ceils, a response that proceeds over a 5-7-d 
period (8). Injected dendritic cells that carry the endogenous 
Mls superantigen can tolerize developing thymocytes to Mls 
antigens over at least 1 wk in situ (47, 48). Third, high levels 
of MHC products on dendritic cells would also enable these 
APCs to display many different peptides or superantigens, 
which may be relevant in responses to complex microbial and 
cellular stimuli. Dendritic cells are found in relatively large 
numbers in synovial effusions (49).  If superantigens are im- 
portant in rheumatoid arthritis as suggested (50, 51), the ability 
of dendritic cells to carry small amounts of superantigen in 
a form that is highly stimulatory for T  cells suggests that 
they would be important APCs for inducing immune re- 
sponses  to these molecules in vivo. 
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